ZBiotics
ZBiotics is a biotechnology company that develops genetically engineered probiotics, including a product designed to break down alcohol byproducts.
Secondary Market Price
Secondary Market Price
How ZBiotics Measures Up
To help you manage your ZBiotics equity, Prospect has run the company through our machine learning model.
Prospect Rating
TBD
We are still gathering data to finalize our rating for ZBiotics. Check back soon for our projection of the company's worth four years from now.
Exit Risk
TBD
We are still gathering data on ZBiotics to train our machine learning model. Check back soon for our exit risk rating for ZBiotics!
Funding Stage
Series A
A company at the Series A stage, like ZBiotics, has already established its product and is now focused on scaling up its operations. This can be a sweet spot for new employees, offering a chance to make a real impact in a growing business that has more stability than a brand-new venture.
Secondary Market Price Chart
Create a free account to unlock real-time secondary market prices and future projections of ZBiotics's value.
Sign up to Unlock the Latest DataData will be available soon.
Sign up to receive notifications when it is available.
Prospect Projected Future ZBiotics Prices
Prospect’s machine learning model has been trained on the same data top-tier investors use to project the likely range of outcomes for ZBiotics's equity. Create a free account to view 10th-90th percentile projections over 2, 4, and 6 years.
Powerful tools to earn more from your equity
Company Description
ZBiotics is a biotechnology research company that develops and commercializes genetically engineered probiotics. The company’s products include a probiotic drink designed to break down a toxic byproduct of alcohol in the gut and a product called ZBiotics Sugar-to-Fiber, which aims to convert dietary sugars into prebiotic fiber. It operates in the healthcare, beverage, biotech, and e-commerce sectors. Founded in 2016 by PhD microbiologist Zack Abbott and Stephen Lamb, the San Francisco-based company has raised a total of $5.7 million in funding across seven rounds.
Looking forward, ZBiotics plans to use its patented technology to expand its product portfolio to address modern health challenges, such as fiber deficiency. A recent development is the company's acquisition of January AI's synbiotic product line, Eden’s, which will merge January AI's prebiotic research with ZBiotics' expertise. The company was recently named the 2025 CPG Award Winner by the ACG Sacramento Network. CEO Zachary Abbott has also made recent appearances on podcasts like "Talking Biotech" and "The Perfect Stool" to discuss the science behind the company's products.
- Spring Tide Capital
- Access Capital
- Seamless Capital
- Goat Rodeo Capital
- Seaside Ventures
- Y Combinator
- Oyster Ventures
- BABEL Ventures
- Co-Founder, CEO Zack Abbott
- Co-Founder, COO Stephen Lamb
Peer Group Comparison
Vs Peer Group of >$4B Startups
Frequently Asked Questions
Joining Anduril as an employee is another way to acquire equity, typically through stock options included in compensation packages.
Is ZBiotics worth joining?
Deciding whether to join a startup like ZBiotics involves evaluating the company's potential and your personal financial goals. Tools like Prospect can help you model the potential value of your equity compensation to make a more informed decision.
What should I do with my ZBiotics stock?
Managing stock in a private company like ZBiotics requires a personalized strategy based on your financial situation and the company's performance. Platforms like Prospect offer tools to help you create customized option exercise strategies and minimize your tax burden.
Can you sell ZBiotics stock?
Selling stock in a private company like ZBiotics is typically possible during specific liquidity events, such as company-approved tender offers or secondary sales. Platforms like Prospect provide tools to help you analyze these opportunities and determine a tax-optimal selling strategy.
How can I find the value of my ZBiotics stock?
Since ZBiotics is a private company, its stock value isn't publicly available but is based on internal valuations from its latest funding round or 409A assessment. You can use a platform like Prospect to upload your equity details and explore predictive models that project the potential future value of your stock.
What is ZBiotics's equity worth?
The total equity valuation of a private company like ZBiotics is established during fundraising rounds and is not public information. Tools like Prospect can help you model different valuation scenarios to understand how they might impact your personal stake.
What is ZBiotics's stock ticker symbol?
Private companies like ZBiotics do not have a stock ticker symbol because their shares are not traded on public stock exchanges. A ticker symbol is only assigned when a company undergoes an Initial Public Offering (IPO).
Can I buy or sell ZBiotics stock?
As a private company, buying or selling ZBiotics stock is generally restricted and not available to the general public on an open market. Transactions typically occur through company-sanctioned secondary sales or tender offers, which platforms like Prospect can help you evaluate.
What is the criteria to buy or invest in ZBiotics stock?
Investing in a private company like ZBiotics is typically limited to accredited investors, venture capital firms, or employees receiving equity as part of their compensation. These opportunities are not generally available to the public and are governed by strict financial regulations.
